A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures

PHASE4CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

November 29, 2017

Primary Completion Date

May 12, 2021

Study Completion Date

May 12, 2021

Conditions
Congenital HemangiomaHemangioendotheliomaAngiosarcomaArteriovenous Malformations
Interventions
DRUG

Lipiodol Ultra Fluid with surgical glues

Lipiodol Ultra Fluid and surgical glue mixture administered via selective arterial catheterization.

Trial Locations (16)

110005

BLK Super Speciality Hospital, New Delhi

110029

AIIMS, New Delhi

122001

Division of Peripheral Vascular & Endovascular sciences, Medanta-The Medicity Hospital, Gurgaon

226014

Sanjay Gandhi Post Graduate Institute of Meducal Sciences (SGPGI), Lucknow

313002

Geetanjali Medical College and Hospital, Udaipur

342005

AIIMS, Jodhpur

411001

B.J Govt College & Sassoon Hospitals, Pune

411011

KEM Hospital, Pune

411033

7 Orange Hospitals, Pune

431003

Mahatma Gandhi Missions Medical college and Hospital, Aurangabad

440009

Government Medical College, Nagpur

442004

Acharya Vinobha Bhave Hospital, Wardha

500096

Apollo Hospital, Hyderabad

560002

Victoria Hospital, Bengaluru

560099

Mazumdar Shaw medical Centre, Bengaluru

590010

KLES Dr. Prabhakar Kore Hospital, Belagavi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Guerbet

INDUSTRY

NCT02625389 - A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures | Biotech Hunter | Biotech Hunter